Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Becker

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal for Immunotherapy of Cancer|April 16, 2022
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansionCamille Le Gall, Anna Cammarata, Lukas de Haas, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignanciesD Mahadevan, E G Chiorean, W B Harris, et al.
European Journal of Immunology|March 21, 2024
cDC2 plasticity and acquisition of a DC3-like phenotype mediated by IL-6 and PGE2 in a patient-derived colorectal cancer organoids modelBeatriz Subtil, Iris A E van der Hoorn, Jorge Cuenca-Escalona, et al.
Journal of Crohn'S & Colitis|November 17, 2018
The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and TherapyC R H Hedin, S R Vavricka, A J Stagg, et al.
Science Advances|September 7, 2019
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineeringJohan M S van der Schoot, Felix L Fennemann, Michael Valente, et al.
Nature Biomedical Engineering|June 8, 2023
Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cellsDavid P Schrijver, Rutger J Röring, Jeroen Deckers, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal for Immunotherapy of Cancer|April 16, 2022
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansionCamille Le Gall, Anna Cammarata, Lukas de Haas, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignanciesD Mahadevan, E G Chiorean, W B Harris, et al.
European Journal of Immunology|March 21, 2024
cDC2 plasticity and acquisition of a DC3-like phenotype mediated by IL-6 and PGE2 in a patient-derived colorectal cancer organoids modelBeatriz Subtil, Iris A E van der Hoorn, Jorge Cuenca-Escalona, et al.
Journal of Crohn'S & Colitis|November 17, 2018
The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and TherapyC R H Hedin, S R Vavricka, A J Stagg, et al.
Science Advances|September 7, 2019
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineeringJohan M S van der Schoot, Felix L Fennemann, Michael Valente, et al.
Nature Biomedical Engineering|June 8, 2023
Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cellsDavid P Schrijver, Rutger J Röring, Jeroen Deckers, et al.
Pageof 5